Bae WK - Search Results

1

Sex-biased genetic programs in liver metabolism and liver fibrosis are controlled by EZH1 and EZH2.

Lau-Corona D, Bae WK, Hennighausen L, Waxman DJ. Lau-Corona D, et al. Among authors: bae wk. PLoS Genet. 2020 May 19;16(5):e1008796. doi: 10.1371/journal.pgen.1008796. eCollection 2020 May. PLoS Genet. 2020. PMID: 32428001 Free PMC article.

2

Canonical and non-canonical roles of the histone methyltransferase EZH2 in mammary development and cancer.

Bae WK, Hennighausen L. Bae WK, et al. Mol Cell Endocrinol. 2014 Jan 25;382(1):593-597. doi: 10.1016/j.mce.2013.05.002. Epub 2013 May 17. Mol Cell Endocrinol. 2014. PMID: 23684884 Free PMC article. Review.

3

The methyltransferase EZH2 is not required for mammary cancer development, although high EZH2 and low H3K27me3 correlate with poor prognosis of ER-positive breast cancers.

Bae WK, Yoo KH, Lee JS, Kim Y, Chung IJ, Park MH, Yoon JH, Furth PA, Hennighausen L. Bae WK, et al. Mol Carcinog. 2015 Oct;54(10):1172-80. doi: 10.1002/mc.22188. Epub 2014 Jul 7. Mol Carcinog. 2015. PMID: 25043748 Free PMC article.

4

The methyltransferases enhancer of zeste homolog (EZH) 1 and EZH2 control hepatocyte homeostasis and regeneration.

Bae WK, Kang K, Yu JH, Yoo KH, Factor VM, Kaji K, Matter M, Thorgeirsson S, Hennighausen L. Bae WK, et al. FASEB J. 2015 May;29(5):1653-62. doi: 10.1096/fj.14-261537. Epub 2014 Dec 4. FASEB J. 2015. PMID: 25477280 Free PMC article.

5

Polymyositis and myocarditis after donor lymphocyte infusion.

Ahn JS, Cho SH, Kim YK, Yang DH, Bae WK, Shim HJ, Lee JJ, Chung IJ, Juhng SW, Kim HJ. Ahn JS, et al. Among authors: bae wk. Int J Hematol. 2009 Jul;90(1):113-116. doi: 10.1007/s12185-009-0332-3. Epub 2009 May 27. Int J Hematol. 2009. PMID: 19472035

6

Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.

Lee SJ, Cho SH, Yoon JY, Hwang JE, Bae WK, Shim HJ, Chung IJ. Lee SJ, et al. Among authors: bae wk. Cancer Chemother Pharmacol. 2009 Dec;65(1):159-66. doi: 10.1007/s00280-009-1019-4. Epub 2009 May 29. Cancer Chemother Pharmacol. 2009. PMID: 19479256 Clinical Trial.

7

Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer.

Bae WK, Hwang JE, Shim HJ, Cho SH, Lee JK, Lim SC, Chung WK, Chung IJ. Bae WK, et al. Cancer Chemother Pharmacol. 2010 Feb;65(3):589-95. doi: 10.1007/s00280-009-1152-0. Cancer Chemother Pharmacol. 2010. PMID: 19830427 Clinical Trial.

8

Phase II study of docetaxel and cisplatin chemotherapy in 5-fluorouracil/cisplatin pretreated esophageal cancer.

Shim HJ, Cho SH, Hwang JE, Bae WK, Song SY, Cho SB, Lee WS, Joo YE, Na KJ, Chung IJ. Shim HJ, et al. Among authors: bae wk. Am J Clin Oncol. 2010 Dec;33(6):624-8. doi: 10.1097/COC.0b013e3181bead92. Am J Clin Oncol. 2010. PMID: 20142726 Clinical Trial.

9

Alpha-type 1-polarized dendritic cells loaded with apoptotic allogeneic myeloma cell line induce strong CTL responses against autologous myeloma cells.

Yang DH, Kim MH, Hong CY, Lee YK, Jin CJ, Pham TN, Ahn JS, Bae WK, Kim YK, Chung IJ, Kim HJ, Kalinski P, Lee JJ. Yang DH, et al. Among authors: bae wk. Ann Hematol. 2010 Aug;89(8):795-801. doi: 10.1007/s00277-010-0931-3. Epub 2010 Mar 18. Ann Hematol. 2010. PMID: 20238114

10

Intratumoral administration of anti-KITENIN shRNA-loaded PEI-alt-PEG nanoparticles suppressed colon carcinoma established subcutaneously in mice.

Park IK, Kim KK, Cho SH, Bae WK, Jere D, Cho CS, Chung IJ. Park IK, et al. Among authors: bae wk. J Nanosci Nanotechnol. 2010 May;10(5):3280-3. doi: 10.1166/jnn.2010.2231. J Nanosci Nanotechnol. 2010. PMID: 20358939

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

304 results

Search Page